4th Quarter - Termination Amendment

DAN COHEN for ALLERGAN INC

Firm
Client
Income
$120,000
Expenses
—
Terminated
Jan 16, 2009

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 16, 2009 $120,000 Replaced
4th Quarter - Termination Amendment (this page) May 27, 2009 $120,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Medical Device Regulation & Legislation

LobbyistCovered position, as disclosed
DANIEL COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.